Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
Launched by SANLIURFA MEHMET AKIF INAN EDUCATION AND RESEARCH HOSPITAL · Jan 13, 2023
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
The study is designed as a single-center, prospective, observational research. A total of 50 stable-course chronic hemodialysis patients over 18 years of age and treated for at least 3 months will be included in the study and the study period will be planned for 12 months. 25 of the 50 chronic hemodialysis patients planned to be included in the study will use MCO-membrane and the other 25 will use high-flux membrane. The distribution of patients to the high-flux membrane and MCO membrane groups will be done randomly (sequentially single-pair number method). Then, the standard 12-hour (3x4 h...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic hemodialysis patients
- • Patients continuing the hemodialysis program for at least 3 months
- • Patients over 18 years of age
- Exclusion Criteria:
- • Patients with advanced heart failure, malignancy, terminal illness
- • Patients with active infectious disease
- • Acute hemodialysis patients
- • Patients vascular access dysfunction
About Sanliurfa Mehmet Akif Inan Education And Research Hospital
Sanliurfa Mehmet Akif Inan Education and Research Hospital is a leading healthcare institution dedicated to advancing medical research and education in the region. As a clinical trial sponsor, the hospital is committed to conducting innovative research that enhances patient care and contributes to the scientific community. With a focus on collaboration and ethical practices, the institution fosters a multidisciplinary approach, engaging healthcare professionals and researchers to explore new treatment modalities and improve health outcomes. Through its comprehensive facilities and expert staff, Sanliurfa Mehmet Akif Inan Education and Research Hospital aims to drive significant advancements in medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
şanlıurfa, Karaköprü, Turkey
Patients applied
Trial Officials
Tuncay Sahutoglu, M.D.
Principal Investigator
Mehmet Akif Inan Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials